Pfizer’s not-so-good year continues.
The New York pharma giant’s shares $PFE slid 7% before Wednesday’s opening bell after Pfizer said it …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
